TAK - TAKEDA PHARMACEUTICAL CO LTD

QQQ $ 629.16 $ 3.02 (0.48 %)

DIA $ 475.66 $ 0.66 (0.14 %)

SPY $ 682.07 $ 2.23 (0.33 %)

TLT $ 90.35 $ -0.27 (-0.3 %)

GLD $ 368.15 $ -2.01 (-0.54 %)

Previous Close

$ 13.44

Open

$ 13.45

Bid

$ 13.25 x 1

Ask

$ 13.59 x 191

Day's Range

$ 13.36 - $ 13.50

52 Week Range

$ 12.80 - $ 15.69

Volume

2,927,215

Average Volume

Market Cap

22.45B

Beta (5Y Monthly)

$ 0.29

PE Ratio (TTM)

$ 31.19

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

takeda-lowers-2025-outlook-after-weak-q2-and-pipeline-impairment-charges

Takeda Lowers 2025 Outlook After Weak Q2 A...
10/30/2025 13:13:01

Takeda posts lower Q2 earnings and trims 2025 outlook as Vyvanse generics, FX headwinds, and impairment charges weigh on revenu...

Earnings Scheduled For October 30, 2025
10/30/2025 11:12:06

Takeda Pharmaceutical Co Lowers FY2025 Adj...
10/30/2025 10:45:13

Takeda Pharmaceutical Co (NYSE:TAK) lowers FY2025 Adj EPS guidance from $3.36 to $3.25. Lowers FY2025 sales outlook from $31.33...

Takeda Pharmaceutical Q2 Adj. EPS $0.43 Mi...
10/30/2025 07:17:51

Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of $0.43 per share which missed the analyst consensus estimate of ...

Takeda's HyHub, HyHub Duo Devices Now Ava...
10/27/2025 12:43:48

Takeda ((

Reported Earlier, Takeda And Innovent Biol...
10/22/2025 07:41:09

Takeda to Receive Rights to Two Next-Generation Late-Stage Investigational Medicines, Worldwide Outside of Greater China, and a...

takeda-taps-nabla-bios-generative-ai-platform-for-antibody-design-in-1-billion-pact

Takeda Taps Nabla Bio's Generative AI Plat...
10/14/2025 18:41:04

Nabla Bio partners with Takeda to use its AI platform JAM for designing antibodies, receiving upfront payments and potential su...

johnson--johnson-in-talks-to-acquire-protagonist-therapeutics-report

Johnson & Johnson In Talks To Acquire Prot...
10/10/2025 17:06:05

Johnson & Johnson is in talks to buy Protagonist Therapeutics in a deal that could expand its immunology and cancer drug po...

whats-going-on-with-nano-cap-galecto-stock-on-tuesday

What's Going On With Nano-Cap Galecto Stoc...
10/07/2025 17:05:49

Galecto stock spiked on heavy trading with no clear news, while the company highlights funding plans, pipeline updates, and cli...

Reported Earlier, Takeda Expands Global CS...
09/24/2025 06:38:22

Takeda, VELA To Transport Products Between...
09/16/2025 12:16:50

Takeda Reports Results From FirstLight And...
09/08/2025 07:25:42

– Takeda is the Leader in Orexin Science and is on Track to Submit Global Regulatory Applications Starting in Fiscal Year 2025–...

On Friday, FDA Approved Takeda's Supplemen...
09/07/2025 16:27:32

Takeda announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (...

Novavax Receives Milestone Payment From Ta...
09/04/2025 12:10:22

Takeda Canada Announces FRUZAQLATM Will No...
08/28/2025 13:31:18

What's Going On With Takeda Stock On Friday?
08/22/2025 15:21:49

Takeda stock steadies after early dip as FDA clears Ionis' Dawnzera for hereditary angioedema, posing fresh competition to ...

ionis-pharma-wins-fda-nod-for-first-rna-targeted-therapy-for-rare-genetic-swelling-disorder

Ionis Pharma Wins FDA Nod For First RNA-Ta...
08/21/2025 18:24:53

FDA approved Ionis' Dawnzera for hereditary angioedema, showing up to 87% attack reduction and strong results in switch pat...

takeda-pharma-maintains-outlook-even-as-vyvanse-generics-hit-sales

Takeda Pharma Maintains Outlook Even As Vy...
07/30/2025 20:04:11

Takeda reported a 30% rise in Q1 profit and beat EPS estimates, offsetting Vyvanse losses with growth in oncology, plasma, and ...

Earnings Scheduled For July 30, 2025
07/30/2025 08:32:48

Takeda Reaffirms FY2025 Guidance, Core Rev...
07/30/2025 06:45:36

FY2025 Outlook (unchanged from May 2025)(Billion yen, except percentages and per share amounts)ItemFY2025 FORECASTFY2025 MANAGE...